advertisement

HIV/AIDS

03 June 2011

New risks for Aids patients

The longevity of Aids patients is widely attributed to the success of ARV drugs, but the rise in cases presents new risks for spreading HIV, the CDC has said.

The longevity of Aids patients is widely attributed to the success of antiretroviral drugs which became widespread in the 1990s, but the rise in cases presents new risks for spreading HIV, the US Centres for Disease Control said.

The CDC's latest Morbidity and Mortality Weekly Report was issued three decades after its 5 June 1981 edition that described unusual cases of pneumonia and Kaposi's sarcoma in five young men in Los Angeles.

 

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.